Cardiovascular prevention

Oxford's Zostavax-to-Shingrix switch closes the healthy-vaccinee loophole, and opens another

A natural experiment at the October 2017 vaccine changeover gives the cardiovascular claim a cleaner comparison group. It also means nobody has yet measured Shingrix against no vaccine.